Deltex Medical Group plc
DEMG.L · LSE
6/30/2024 | 12/31/2023 | 6/30/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Revenue | £1 | £1 | £1 | £1 |
| % Growth | 48.4% | -32.3% | -20% | – |
| Cost of Goods Sold | £0 | £0 | £0 | £0 |
| Gross Profit | £1 | £0 | £1 | £1 |
| % Margin | 66.8% | 55.4% | 66.9% | 73% |
| R&D Expenses | £0 | £0 | £0 | £0 |
| G&A Expenses | £1 | £0 | £1 | £1 |
| SG&A Expenses | £1 | £1 | £1 | £1 |
| Sales & Mktg Exp. | £0 | £0 | £0 | £0 |
| Other Operating Expenses | £0 | £0 | £0 | £0 |
| Operating Expenses | £1 | £1 | £1 | £1 |
| Operating Income | -£0 | -£1 | -£1 | -£0 |
| % Margin | -41.5% | -88.6% | -51.6% | -31.5% |
| Other Income/Exp. Net | -£0 | -£0 | -£0 | -£0 |
| Pre-Tax Income | -£1 | -£1 | -£1 | -£1 |
| Tax Expense | £0 | -£0 | -£0 | -£0 |
| Net Income | -£1 | -£1 | -£1 | -£0 |
| % Margin | -51.3% | -103.9% | -50.8% | -36.5% |
| EPS | -0 | -0 | -0.001 | -0.001 |
| % Growth | 25% | 50% | -14.3% | – |
| EPS Diluted | -0 | -0 | -0.001 | -0.001 |
| Weighted Avg Shares Out | 1,896 | 1,659 | 704 | 699 |
| Weighted Avg Shares Out Dil | 1,892 | 1,659 | 703 | 699 |
| Supplemental Information | – | – | – | – |
| Interest Income | £0 | £0 | £0 | £0 |
| Interest Expense | £0 | £0 | £0 | £0 |
| Depreciation & Amortization | £0 | £0 | £0 | £0 |
| EBITDA | -£0 | -£1 | -£0 | -£0 |
| % Margin | -37.9% | -91.4% | -37.7% | -26.1% |